Company Overview and News
The stock market has been on an epic run. Since the 2008 Recession, the S&P 500 has gone on its longest bull run ever and has risen by more than 300% during that stretch.
HD FB SQ SHOP M NFLX GOOG NVDA CRM WMT ADBE TGT JWN AMZN GOOGL AAPL AAXN
Shares of several popular Canadian marijuana producers—including Tilray (TLRY - Free Report) , Canopy Growth (CGC - Free Report) , and Cronos Group (CRON - Free Report) —were surging once again on Wednesday as Wall Street grows ever-more bullish on the prospects of legalization and U.S. imports.
SHOP UNP CRON WEED CGC TLRY GWP
On today’s episode of the Tech Talk Tuesday podcast, Ryan McQueeney discusses the intersection of disruptive technology and the budding marijuana industry, ultimately concluding that investors should remember what they’ve learned about investing in other forms of new tech as it becomes a bigger factor in the cannabis business.
SHOP TXN CRON WEED CGC TLRY
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
SHOP WEED CGC
2018-09-17 zacks - 2
On today’s episode of Free Lunch, Associate Stock Strategist Ryan McQueeney touches on the trade war’s latest tariff threats and a key FDA approval for Teva Pharmaceuticals. He also highlights two surprising companies which might have a chance to profit from the marijuana boom.
SHOP GSKY TWTR FDX ORCL
Despite being hyped and talked about a lot, still very few people own Bitcoin, and even fewer use it regularly, as quantified estimates point to around 3 million active users.
2018-09-10 investorplace - 1
Trying to invest in e-commerce outfit Shopify (NYSE:SHOP) is maddening. There’s no other way to say it. The problem is that Shopify stock can (and will) stop and reverse course at the drop of a hat and with no warning.
SHOP AMZN WMT
2018-09-10 investorplace - 7
Amazon.com, Inc. (NASDAQ:AMZN) has been one of the more impressive stocks of the past 25 years. In fact, AMZN now has returned well over 100,000% from its initial public offering (IPO) price of $18 ($1.50 adjusted for the company’s subsequent stock splits).
JD FB SQ SHOP F WDAY NFLX BBY GOOG WMT WFM BABA AMZN GOOGL ROKU
2017-11-09 - Asif
Shopify provides the leading cloud-based, multi-channel commerce platform designed for small and medium-sized businesses. Merchants use its software to run their business across all of their sales channels, including web and mobile storefronts, physical retail locations, social media storefronts, and marketplaces. As the number of channels over which merchants transact continues to expand, the importance of a multi-channel platform that is both fully integrated and easy to use increases. The Shopify platform provides merchants with a single view of their business and customers across all of their sales channels and enables them to manage products and inventory, process orders and payments, ship orders, build customer relationships and leverage analytics and reporting all from one integrated back office. Commerce transacted over mobile devices continues to grow more rapidly than desktop transactions. For several years Shopify has focused on enabling mobile commerce and its merchants ...
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
2018-09-18 - Asif
Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...
2018-09-18 - Asif
Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...
Silicon Investor Message Boards
This table lists all message boards related to SHOP / Shopify Inc. on message board site Silicon Investor.
as of ET